PT. Merck Indonesia Tbk. (MERK) operates in the pharmaceutical and chemical business in Indonesia. In pharmaceutical, the company manufactures the following products: Neurobion®, Sangobion® and Glucophage®. While in chemical business, MERK markets a whole range of laboratory reagents, pigments and other specialty chemicals. MERK was listed on Indonesia Stock Exchange in 1981 under the Development Board. The company was founded in 1970 and based in Jakarta, Indonesia. MERK operates as a subsidiary of Merck KGaA, a pharmaceutical company based in Darmstadt, Germany.
Headquarters
Jl Tb Simatupang, No 8, Pasar Rebo
Jakarta; Jakarta;
Postal Code: 13760
Contact Details: Purchase the Pt Merck Tbk report to view the information.
Website: http://www.merck.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service